It was invented by researchers from the "American of Sharjah" and obtained a patent
A new approach to treating breast cancer protects against "debilitating effects"
The team obtained the patent on December 15th.
Archives
Ghaleb al-Husseini: "The program uses micro-capsules that target cancer cells, bypassing healthy cells in the body."
picture
A team of American University of Sharjah researchers has obtained a patent in the United States for targeted treatment systems and methods for breast cancer, as the team applied for the patent in 2017 and it was issued on December 15th.
The group of researchers, known as the "Ultrasound Group in Cancer Research" is working on a chemotherapy program that uses microcapsules that target cancer cells bypassing healthy cells in the body, thus reducing the negative effects of chemotherapy. This innovation can help cancer patients avoid some side effects. Harsh, and sometimes debilitating, current treatments.
“The patent describes a chemotherapy program consisting of nanotransmitters that use the drug Herceptone and encapsulate many antagonists,” said a professor of chemical engineering and a professor of chemical engineering at the American University of Sharjah and founder of the Ultrasound Cancer Research Group at the university, Dr. Ghaleb Al-Husseini. For tumors (anti-cancer) as soon as the nanocomposites reach the breast cancer tissue and are attached to it, and the drug is released using ultrasound, which ensures that high concentrations of treatment reach the diseased tissues, while avoiding their interaction with healthy cells in the body, thus reducing the side effects of treatment Traditional chemist ».
“Using this method, nanotransmitters target a type of protein called (human epidermal growth factor receptor 2) (HER2), which promotes the growth of cancer cells, and once the nanotransmitters bind to the malignant cells, ultrasound is used to release the chemotherapy drug at the site. Target ».
Al-Husseini explained that “the use of ultrasound is ideal, because it is easy to use and widely understood. The drug delivery group at the American University of Sharjah is also working on related research to fight breast cancer, and researchers in this group have also applied for a patent in the states. The United Nations therapy for treatment based on the use of the hormone estron and liposomes, to deliver chemotherapy in the treatment of breast cancer, and these research studies provided an opportunity for graduate and undergraduate students specializing in chemical, biomedical and electrical engineering at the university to gain research experience within their work in research teams.
efforts
Dr. Ghaleb Al Husseini expressed his appreciation for the efforts and innovations of the university’s students, whom we rely heavily on in our work. The credit for the success of this research goes to members of the Drug Delivery Group at the American University of Sharjah, especially the faculty members, visiting scientists and postdoctoral fellows. .
Follow our latest local and sports news, and the latest political and economic developments via Google news